{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:10:12Z","timestamp":1787505012089,"version":"build-2736575974"},"reference-count":68,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Cardiovascular Therapy"],"published-print":{"date-parts":[[2020,4,2]]},"DOI":"10.1080\/14779072.2020.1749596","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T11:44:24Z","timestamp":1585655064000},"page":"175-180","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Icosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterol"],"prefix":"10.1080","volume":"18","author":[{"given":"Najdat","family":"Bazarbashi","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Maryland School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.010"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-61-5-888"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu500"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32519-X"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2012.01.009"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0046"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-011-0219-7"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suw009"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2013.05.002"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3213"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.10.038"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.31"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812792"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2008.046"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20045"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169180"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.07.035"},{"key":"cit0020","unstructured":"FDA. FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups. (U.S Food and Drug Administration Website). 2019."},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91755-8"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.040"},{"key":"cit0023","volume-title":"Endotext","author":"Feingold KR","year":"2018"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1991.tb01883.x"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001282"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67667-2"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e328341a5a8"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2018.09.011"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.234"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e31816b43d3"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e3283613a68"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.10.031"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht055"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107579"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.02.004"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60527-3"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-019-0131-8"},{"key":"cit0038","unstructured":"AstraZeneca. (Update on Phase III STRENGTH trial for Epanova in Mixed Dyslipidimia). 2020."},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23055"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2018.1511919"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000482"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.04.015"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.05.031"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000709"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.5551\/jat.E091"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-0294"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2019.10.014"},{"key":"cit0048","unstructured":"VASCEPA. (VASCEPA Label). 2019."},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2014.11.2828"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.11.008"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.70"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M200282-JLR200"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2019.1607414"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-0352"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2016.04.026"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.032"},{"key":"cit0057","unstructured":"Association FaD. (FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups). 2019, Dec 13."},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S010"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-019-0762-1"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1177\/0003319719842005"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2019.10.008"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-019-0762-1"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz329"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2018.01.002"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.01.062"},{"key":"cit0067","unstructured":"Budoff MJ, Roy S, Tayek J, et al. Effect of Icosapent Ethyl on progression of coronary Atherosclerosis in patients with elevated Triglycerides on Statin therapy - EVAPORATE. Philadelphia, PA: Annual Scientific Sessions of the American Heart Association; 2019. p.16\u201318. https:\/\/www.abstractsonline.com\/pp8\/#!\/7891\/presentation\/35090"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2017.07.007"}],"container-title":["Expert Review of Cardiovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14779072.2020.1749596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T06:47:29Z","timestamp":1620456449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14779072.2020.1749596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,2]]}},"alternative-id":["10.1080\/14779072.2020.1749596"],"URL":"https:\/\/doi.org\/10.1080\/14779072.2020.1749596","relation":{},"ISSN":["1477-9072","1744-8344"],"issn-type":[{"value":"1477-9072","type":"print"},{"value":"1744-8344","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierk20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierk20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}